Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on CVS Health to $85 from $80 and keeps an Outperform rating on the shares. Following the company’s investor day, Evercore says the firm liked the company’s new approach to guidance, which “conservatively” points to 6% EPS growth with the opportunity for upside in a variety of areas.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CVS:
- CVS Health (NYSE:CVS) Rises on Bullish FY24 Outlook and Dividend Hike
- CVS Health to hold investor day
- CVS Health increases quarterly dividend 10% to 66.5c per share
- CVS Health sees FY24 adjusted EPS at least $8.50, consensus $8.51
- CVS Health back FY23 adjusted EPS view $8.50-$8.70, consensus $8.58
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue